SEC Form 4 · accession 0001013606-16-000265
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jose A. Lima
Officer — VP-Quality
Period of report
Jun 1, 2016
Accepted (ET)
Jun 2, 2016 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2016 | A | 7,535 | $0.00 | A | 38,841 | D | |
| Common StockF2 | Jun 1, 2016 | S | 957 | $12.55 | D | 37,884 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on June 1, 2015. 33% percent of the shares subject to this award vested upon one year of service.
- F2Shares sold on June 1, 2016 to satisfy statutory minimum tax withholding obligations related to Restricted Stock Unit shares vested on May 28, 2016.